tiprankstipranks
Trending News
More News >
Exelixis (EXEL)
NASDAQ:EXEL

Compare Exelixis (EXEL) vs. Competitors

Compare
3,126 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Exelixis
$45.44
$12.18B
18.51
20.27%
6 Buy
8 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$55.07
$10.58B
20.45
-10.87%
14 Buy
5 Hold
0 Sell
Moderate Buy
Halozyme
$71.82
$8.45B
14.97
28.61%
4 Buy
2 Hold
1 Sell
Moderate Buy
Incyte
$106.21
$20.66B
17.82
46.56%
9 Buy
9 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$215.04
$13.14B
-48.46
56.38%
13 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$76.26
$14.70B
-18.21
123.57%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EXEL
Exelixis
43.96
7.53
20.67%
BMRN
BioMarin Pharmaceutical
54.59
-7.94
-12.70%
HALO
Halozyme
71.21
15.27
27.30%
INCY
Incyte
106.21
32.74
44.56%
ASND
Ascendis Pharma
205.83
74.77
57.05%
BBIO
BridgeBio Pharma
76.26
40.18
111.36%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts